NOVOZYMES A/S SPONS.ADR 1 (NZM) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.015x

Based on the latest financial reports, NOVOZYMES A/S SPONS.ADR 1 (NZM) has a cash flow conversion efficiency ratio of 0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€167.10 Million ≈ $195.36 Million USD) by net assets (€10.92 Billion ≈ $12.77 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NOVOZYMES A/S SPONS.ADR 1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how NOVOZYMES A/S SPONS.ADR 1's cash flow conversion efficiency has evolved over time, based on yearly financial data. See shareholders equity of NOVOZYMES A/S SPONS.ADR 1 for net asset value and shareholders' equity analysis.

NOVOZYMES A/S SPONS.ADR 1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NOVOZYMES A/S SPONS.ADR 1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ABN Amro Group NV
AS:ABN
0.009x
Willis Towers Watson PLC
NASDAQ:WTW
0.096x
American Water Works
NYSE:AWK
0.070x
NATURGY ENERGY ADR1/5/E01
F:GANA
0.136x
Epiroc AB (publ)
ST:EPI-A
0.074x
XPO Logistics Inc
NYSE:XPO
0.099x
Sterling Construction Company Inc
NASDAQ:STRL
0.139x
Repsol S.A
F:REPA
0.036x

Annual Cash Flow Conversion Efficiency for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see NZM market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €10.86 Billion
≈ $12.69 Billion
€1.22 Billion
≈ $1.43 Billion
0.113x +23.31%
2024-12-31 €11.18 Billion
≈ $13.07 Billion
€1.02 Billion
≈ $1.19 Billion
0.091x -68.46%
2023-12-31 €1.93 Billion
≈ $2.25 Billion
€557.10 Million
≈ $651.31 Million
0.289x +2.75%
2022-12-31 €1.91 Billion
≈ $2.23 Billion
€537.65 Million
≈ $628.57 Million
0.282x -15.39%
2021-12-31 €1.64 Billion
≈ $1.92 Billion
€546.17 Million
≈ $638.53 Million
0.333x --

About NOVOZYMES A/S SPONS.ADR 1

F:NZM Germany Specialty Chemicals
Market Cap
$24.08 Billion
€20.60 Billion EUR
Market Cap Rank
#1088 Global
#250 in Germany
Share Price
€50.00
Change (1 day)
+0.00%
52-Week Range
€44.80 - €66.00
All Time High
€67.43
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more